Literature DB >> 11091757

Argyrophilic Nucleolar Organizer Regions of Breast Tumors: Assessment of Aspirated Cytological Materials.

.   

Abstract

To investigate the correlation between argyrophilic nucleolar organizer regions (Ag-NORs)and the malignant potential of breast tumors, we analyzed Ag-NORs of cytological specimens obtained from 190 patients with various types of breast disease by preoperative aspiration biopsy. The average number of Ag-NORs per nucleus was defined as the Ag-NOR score. The Ag-NOR score was 5.7 +/- 1.7 in the group of women with breast carcinoma (n =70), 2.6= 0.4 in the group with fibroadenoma (n= 54) and 2.9= 0.6 in the group with mastopathy (n= 66). The level was significantly higher in breast carcinoma than in each benign disease(P < 0.001 in both cases). The score was 6.5 +/- 2.3 in the group with four or more metastatic lymph nodes (n = 21), 5.2+/- 1.2 in the group with one to three metastatic lymph node (n= 10) and 5.1+/- 1.1 in that with no metastatic lymph node (n = 39);the score was significantly (P < 0.05) higher in the groups with four or more metastatic lymph modes than in the other groups, respectively. Thus, a correlaton was observed between the Ag-NOR score and lymph node status. These data suggest that a higher Ag-NOR score reflects high-grade malignancy.

Entities:  

Year:  1996        PMID: 11091757     DOI: 10.1007/BF02966984

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  26 in total

1.  Measurement of bromodeoxyuridine labeling index, Ki-67 score and Ag-NOR count in breast carcinomas. Comparison with DNA ploidy.

Authors:  K Sasaki; K Matsumura; T Murakami; T Tsuji
Journal:  Oncology       Date:  1992       Impact factor: 2.935

2.  Evaluation of nucleolar organizer region-associated proteins in breast malignancy.

Authors:  R Smith; J Crocker
Journal:  Histopathology       Date:  1988-02       Impact factor: 5.087

3.  An improved technique for selective silver staining of nucleolar organizer regions in human chromosomes.

Authors:  S E Bloom; C Goodpasture
Journal:  Hum Genet       Date:  1976-10-28       Impact factor: 4.132

4.  Nucleolar organizer regions relate to growth fractions in human breast carcinoma.

Authors:  W A Raymond; A S Leong
Journal:  Hum Pathol       Date:  1989-08       Impact factor: 3.466

5.  Ag-NOR technique in fine needle aspiration cytology of salivary gland masses.

Authors:  M R Cardillo
Journal:  Acta Cytol       Date:  1992 Mar-Apr       Impact factor: 2.319

6.  A comparative study of histopathology, hormone receptors, peanut lectin binding, Ki-67 immunostaining, and nucleolar organizer region-associated proteins in human breast cancer.

Authors:  D Di Stefano; P L Mingazzini; L Scucchi; M Donnetti; V Marinozzi
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

7.  [Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].

Authors:  T Tominaga; Y Yoshida; M Kitamura; G Kosaki
Journal:  Gan To Kagaku Ryoho       Date:  1985-09

8.  Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.

Authors:  W A Mourad; B Erkman-Balis; S Livingston; M Shoukri; C E Cox; S V Nicosia; D T Rowlands
Journal:  Cancer       Date:  1992-04-01       Impact factor: 6.860

9.  Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.

Authors:  J Freeman; D B Kellock; C C Yu; J Crocker; D A Levison; P A Hall
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

10.  Cytophotometric DNA content and argyrophilic nucleolar organiser regions of oesophageal carcinoma.

Authors:  M Morita; H Kuwano; S Tsutsui; S Ohno; H Matsuda; K Sugimachi
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  1 in total

1.  Role of proliferative markers in breast lesions.

Authors:  Asim Kumar Manna; Swapan Pathak; Diptendra Kumar Sarkar
Journal:  Indian J Surg       Date:  2010-02-05       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.